Icad, INC

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$2.4Mgeneral payments (2019-2025)
$218Kresearch payments (2019-2025)
232clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $107K
2020 $549K
2021 $834K
2022 $500K
2023 $139K
2024 $259K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Radiation Oncology $1.3M
Diagnostic Radiology $539K
Neurology (Psychiatry & Neurology) $257K
Surgery $104K
Surgical Oncology $95K
Dermatology $41K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Rakesh Patel Los Gatos, CA Radiation Oncology $1,305,921.86
Santosh Kesari Santa Monica, CA Neurology (Psychiatry & Neurology) $256,513.99
Randy Hicks Flint, MI Diagnostic Radiology $98,006.66
Linda Moy New York, NY Diagnostic Radiology $93,750.00
Stamatia Destounis Rochester, NY Diagnostic Radiology $82,560.00
Emily Fox Conant Philadelphia, PA Diagnostic Radiology $67,976.36
Hedvig Hricak New York, NY Diagnostic Radiology $62,630.80
Mark Traill Wyoming, MI Diagnostic Radiology $51,933.63
Peter Beitsch Dallas, TX Surgical Oncology $46,788.93
Walton Taylor Dallas, TX Surgery $46,788.93

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.